News for LeviteeLabs (LVT.CN)

VANCOUVER, British Columbia, Feb. 01, 2022 (GLOBE NEWSWIRE) — Levitee Labs Inc. (CSE: LVT) (OTC: LVTTF) (FSE: 7H7) (the “ Company ” or “ Levitee ”) is…

Wellness company Levitee Labs Inc. (CSE:LVT) (OTC:

The agreement is anticipated to contribute to correcting the opioid crisis in Canada and serve as a foundation for both companies to potentially expand into…

VANCOUVER, British Columbia, Jan. 06, 2022 (GLOBE NEWSWIRE) — In a press release issued earlier today under the same headline by Levitee Labs Inc. (CSE: LVT)…

Stocks2Watch Investor Series today announced their agenda is set for the Investor Luncheon with Special Guest, Bruce Campbell from StoneCastle Investment Management, Tuesday November 30. Individual... | November 18, 2021

Signed LOI to acquire 100% interest in chain of specialty addiction pharmacies in Vancouver, BC Acquisition price of $4.0 million based upon approximately

Levitee Labs achieves combined September 2021 and October 2021 revenues of $1,553,728 Consistent revenue growth and acquisitions across core divisions of ...

Levitee Labs acquiring 51% interest in new R&D compounding pharmacy in Calgary, Alberta, Canada New pharmacy to focus on production of intranasal ketamine

Levitee Labs will be a Gold Sponsor and VIP Lounge Sponsor at the world's largest psychedelic medicine conference If you would like to attend either of